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Biodegradable microspheres used as controlled release systems are important in pharmaceutics. Chitosan bio-
polymer represents an attractive alternative to other biomaterials because of its signiﬁcant physicochemical
and biological behaviors. Chitosan microspheres are expected to become promising carrier systems for drug
and vaccine delivery, especially via oral,mucosal and transdermal routes. Controlling the swelling rate and swell-
ing capacity of the hydrogel and improving the fragile nature ofmicrospheres under acidic conditions are the key
challenges that need to be overcome to allow the use of chitosanmicrospheres for controlled or sustained release
specially via these non-invasive administration routes.
There have beenmany studies on themodiﬁcation of chitosan microsphere structures with cross-linkers, blends
with various kinds of polymers and new organic–inorganic hybrid systems in order to obtain some improved
properties. In this work, microspheres composed of chitosan and nanosized hydrophobic silica commercialized
under the name Aerosil R972 were generated by a method consisting of two steps: ﬁrst, preparation of a macro-
scopically homogeneous chitosan–hydrophobic silica dispersion by an optimized procedure, and then drying.
Spray dryingwas the technique used here. FTIR spectroscopy, X-ray powder diffraction, differential scanning cal-
orimetry, thermal gravimetric analysis, Scanning Electron Microscopy (SEM) and high resolution Transmission
ElectronMicroscopy (TEM)were used to characterize themicrospheres, besides acid stability, moisture sorption
capacity, release properties and biological assays.
The chitosan–hydrophobic silica composite microspheres showed improved thermal degradation, lower water af-
ﬁnity, better acid stability and ability to retard rifampicin (drug model) release under simulated gastric conditions.
In vitro biocompatibility studies indicated low cytotoxicity and low capacity to activate cell production of the pro-
inﬂammatory mediator nitric oxide, encouraging further studies on the use of the new chitosan–hydrophobic silica
composite microspheres as drug carrier systems via oral or nasal routes.
1. Introduction
Chitosan is a biopolymer derived from chitin, a natural polysaccha-
ride usually obtained from carapaces of marine crustaceans such as
crabs and shrimps [1]. Due to its natural origin, chitosan cannot be de-
ﬁned as a unique chemical structure, but as a family of polymers of dif-
ferentmolecularweights and degrees of deacetylation, deﬁned in terms
of the percentage of primary amino groups in the polymer backbone [2].
Chitosan has many physicochemical (reactive hydroxyl and amino
groups, high positive charge in acidic conditions, good ﬁlm formation)
and biological (biocompatible, biodegradable, lack of toxicity, antimi-
crobial effects, mucoadhesive character) properties, that make it an
attractive material for use as a new functional material of high potential
in ﬁelds as different as biomedical [3–5], food [6–9], water treatment
[5,10–12], and agricultural [9,12,13], among others. Chitosan has, for
example, the ability to bind to particular materials including proteins,
metal ions, and even tumor cells. Moreover, chitosan can be incorporat-
ed into hydrogels and microspheres which demonstrate large potential
in delivery systems for drugs via oral, nasal or transdermal routes
[14–18].
Chitosan has many advantages, particularly for developing nano/
microspheres as carrier systems. These include its ability to control the
release of active agents and to avoid the use of hazardous organic sol-
ventswhile fabricating particulate systems, since it is soluble in aqueous
acidic solution. However, the stability of the chitosan microspheres
under different physiological conditions is a prerequisite for their suc-
cessful application. For example, microspheres intended for nasal ad-
ministration have to be optimized in terms of particle size and surface
charges necessary to induce mucoadhesiveness. Chitosan has been
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shown to possess mucoadhesive properties owing to the electrostatic
interaction between its positive charges and negatively charged muco-
sal surfaces. However, chitosan microspheres absorb water, swell and
become too fragile after being swollen, losing their rigidity and shape,
which can clog the nostrils and hampers intranasal delivery. Another
example is the considerable limitation of chitosan microspheres as
sustained release carrier systems for oral administration. Chitosan rap-
idly adsorbs water, swells and dissolves under gastric conditions, lead-
ing to fast drug release.
In order to overcome these problems, it is possible tomodify the chi-
tosan structure by introducing cross-linking structure, blending chito-
san with synthetic polymers such as poly(vinyl alcohol) (PVA) [19],
and developing organic–inorganic hybrid membranes [20].
Cross-linking is a common way to improve the controlled-release
properties and mechanical strength by introducing a three-dimensional
network structure [21]. Consequently, the motion of solutes across
cross-linked polymermembranes can be controlled by precisely control-
ling this network structure. The available amino and hydroxyl groups on
chitosan are active sites capable of forming a number of linkages. To
date, themost common cross-linkers used involving bonds with chitosan
amine groups are aldehydes, such as glutaraldehyde [22–24], formalde-
hyde [25,26] or glyoxal [27,28]. Epichlorohydrin, a bifunctional molecule
which contains two functional groups, is another cross-linker reagent
highly reactive with the hydroxyl groups of chitosan [29,30].
Cross-linked chitosan networks are highly useful in the pharmaceu-
tical ﬁeld for the formulation of various novel drug delivery systems like
microspheres, nanospheres and ﬁlms/membranes. However, accep-
tance of such cross-linked products depends upon the amount of
cross-linking agent present in the ﬁnal products. In that sense, the tox-
icity of aldehydes has enormously limited the exploitation of the cross-
linked chitosan microparticles in the pharmaceutical ﬁeld [31,32]. To
overcome toxicity, Ré and co-workers have also long been studying
the potential use of d,l-glyceraldehyde as a biocompatible cross-linking
agent, since it is present in the human organism as a metabolic product
of fructose. The morphology, particle size, surface charge and water-
uptake capacity properties of the cross-linked chitosan microspheres
have been characterized and published [33,34].
In another way, chitosan–clay nanocomposites have been syn-
thesized as coating materials for tablets to retard acid swelling and im-
provement of ﬁlm stability in gastric ﬂuid. Clays are composed of silicate
layers. The silicate layers can be separated and form three-dimensional
structures when they are hydrated in water. They have negative charge
and can interact with chitosan. It was found that chitosan reacts with
several types of clays such as montmorillonite [35–38], magadiite [39],
rectorite [20] or magnesium aluminum silicate [40] for modiﬁed-
release tablets. Montmorillonite chitosan nanocomposites have been
proposed as new drug delivery for oral administration combining
mucoadhesive properties with low solubility in acidic environment for
modiﬁed drug delivery formulations [37].
Silica has already been combined with chitosan to synthesize silica–
chitosan hybrid materials by sol–gel process under acid conditions in
various structures such as hierarchical porous materials and composite
membranes [16,40–43].Weproposed here an alternativeway to control
chitosan microsphere properties such as moisture sorption capacity,
acid stability, surface charge and release properties by combining chito-
san with nanosized organic silica oxide named Aerosil R972 into chito-
san composite microspheres. The objective of this work was to produce
chitosan–Aerosil R972 composite microspheres by spray drying and to
examine the role of the nanosized modiﬁed silica in modifying their
properties.
2. Materials
Lowmolecularweight chitosan (75–85% deacetylated chitosan)was
purchased from Sigma-Aldrich (St. Louis, MO, USA). Hydrophobic silica
named Aerosil R972 (primary particle size of 16 nm, speciﬁc surface
area of 110 ± 20 m2 g−1) was supplied by Degussa-Huls Corporation,
Brazil. Analytical grades of absolute ethanol, anhydrous acetic acid, di-
methyl sulfoxide, hydrochloric acid and sodium hydroxide used in this
study were provided by Synth (Brazil).
Cell culture reagents: Dulbecco Modiﬁed Minimum Essential Medi-
um (DMEM) and heat inactivated fetal calf serum were obtained from
Cultilab, Brazil; lipopolysaccharide, Triton X-100 and the Griess re-
agents were from Sigma Aldrich. The lactate dehydrogenase kit was
purchased from Doles, Brazil. Rifampicin, C43H58N4O12 (structural for-
mula given in Fig. 1), was used as drug model. The rawmaterial (purity
N99%) was obtained from Luohe Nanjiecun Pharmaceutical (Group
Pharmacy China) and used without further puriﬁcation.
3. Methods
3.1. Measurements of the contact angle of ethanol–water solutions on
Aerosil R972
The ﬁrst problem to be solved in this study was how to properly dis-
perse a hydrophobic nanosized material like Aerosil R972 into an aque-
ous solution of chitosan.We proposed the introduction of ethanol in the
mixture to facilitate the silicawetting and dispersion. To deﬁne the con-
centration values of ethanol/watermixtures to beused, theAerosil R972
powder was pressed in tablets and the wetting of water/ethanol
mixtures on the silica tablet surfaces was analyzed by the sessile
drop method coupled with digital image analysis. Brieﬂy, a liquid
drop of water/ethanol mixture was gently deposited on the solid sub-
strate and theproﬁle of thedropwas captureddigitally byusing anoptical
microscope.
3.2. Preparation of chitosan–Aerosil R972 microspheres
The chitosan solution (1 g) was prepared by dissolving the polymer
in deionized water containing 3% w/v acetic acid (approximately 80 ml).
The mixture was maintained under mechanical stirring for 30 min. After
complete dissolution the pH was adjusted to 5.5–6.0 with a 0.5 M NaOH
solution.
In order to facilitate the dispersion of the nanosized particles of Aerosil
R972 in the aqueous chitosan solution, they were ﬁrst wetted with abso-
lute ethanol (approximately 25 ml). Next, the ethanolic dispersion was
added to the chitosan solution under stirring (200 rpm) to give, after
this dilution, a dispersion containing 20% w/w ethanol, able to ensure sil-
ica wetting in the hydroalcoholic dispersion. We then homogenized the
dispersion in order to break potential particle aggregates, using a high-
pressure homogenizer (model APV-2000, Stansted Fluid Power, APV,
USA) operated at 800 bar for ﬁve homogenization cycles (15 min).
Chitosan–Aerosil R972 microspheres were then produced with the
subsequent removal of the solvent of the homogenized suspensions.
Fig. 1. Chemical structure of the drug model (rifampicin) used in this study.
Theywere spray dried with a 0.5 mm two-ﬂuid pressurized atomizer at
a feed rate of 3 ml min−1 in a Büchi-B190 spray dryer (Buchi
Labortechnik AG, Flawil, Switzerland). The atomizing air ﬂow rate was
600 NL/h. The inlet temperature was controlled at 120 ± 2 °C and the
outlet temperature at 89 ± 3 °C. The experiments were made in
triplicate.
Before spray drying, the viscosities of the hydroalcoholic dispersions
weremeasured at 5 rpmand at 25 ± 0.2 °Cwith a Brookﬁeld viscometer
(DV-III Ultra). The viscometer was operated with spindle no. SC4-31. The
viscosity values were analyzed with the Brookﬁeld's Rheocalc software.
3.3. Characterization of chitosan–Aerosil R972 microspheres
3.3.1. Particle size, surface area, morphology and zeta potential
Particle size distributions were determined using a laser diffraction
particle size analyzer in the polarization intensity differential scattering
(PIDS) optical mode (Beckman Coulter, model LS 230, Miami, FL). Sam-
ples of spray dried powders were dispersed in mineral oil, until the re-
quired obscuration (about 40% PIDS) was achieved. Average particle
size was expressed as the volume mean diameter (D4.3). Polydispersity
was given by a span index, whichwas calculated by (D0.9 − D0.1) / D0.5,
where D0.9, D0.5 and D0.1 are the particle diameters determined respec-
tively at the 90th, 50th and 10th percentiles of undersized particles. The
measurements were performed in triplicate.
The surface areawasmeasured by the technique of Brunauer, Emmett
and Teller (BET), using the equipment ASAP 2010, Micromeritics (USA).
Microparticle samples were weighted (0.5 g) in glass tubes and pre-
treated to removemoisture in an ovenwith circulating air at 50 °C for ap-
proximately 12 h. In the range of validity of the BET isotherm, the speciﬁc
areawas calculated from the slope and intercept of the line formedbyﬁve
points of measurement.
The particleswere observed by Scanning ElectronMicroscopy (SEM)
(JEOL JSM-6360LV, Japan) after Au coating and by Transmission Elec-
tronMicroscopy (TEM) (Philips CM120 80 kV) after embedding themi-
crospheres with Spur epoxy resin and microtome-sectioning for TEM
analysis.
The zeta potential wasmeasured by electrophoretic mobility using a
DelsaNano C (Beckman Coulter, USA). All samples were dispersed in
deionized water and the pH was adjusted (4.0 to 7.4) by adding HCl
0.5 M or NaOH 0.5 M. Each zeta potential value reported is an average
of at least 10 measurements.
3.3.2. Structural characterization
The moisture content was measured by Karl Fisher titration in dry
methanol using a DL38 titrator (Mettler-Toledo, Switzerland).Measure-
ments were made in triplicate.
FTIR spectrawere recordedonaNicolet 6700 FTIR- spectrophotometer
(Thermo Scientiﬁc, USA) using aKBr disk in the range of 4500–500 cm−1,
with 4 cm−1 resolution.
TG curves of samples were obtained by a TG-Mark Mettler Toledo,
Model SDTA851. A standard sample holder of alumina ceramic (Al2O3)
was used. The samples were weighed on a precision balance Mettler
Toledo Brand, Model XS205. The analyzes were performed under an
atmosphere of oxygen at a ﬂow rate of 50 ml min−1, from 0 to 800 °C
at a heating rate of 10 °C min−1. The inorganic content of the spray
dried powders was determined by weighting the remaining ash after
complete degradation of the samples at 800 °C.
TheDSC thermograms of the sampleswere obtained by aDifferential
Scanning Calorimeter DSC822 (Mettler Toledo) using a standard alumi-
num sealed sample holder where the samples were weighed on a pre-
cision balance Mettler Toledo Brand, Model XS205. The analyses
were performed under an atmosphere of oxygen at a ﬂow rate of
50 ml min−1 in the temperature range of 20–450 °C at a heating
rate of 10 °C min−1.
For DRX analysis the samples were pressed in an aluminum sample
holder and data were collected on an X-ray diffractometer Shimadzu,
XRD 6000, CuKα radiation (λ = 1.5418 A), operating at 40 kV and
40 μA voltage and tube current, respectively. The scan was made over
the range 2Θ from 5 to 40° with a step of 0.02° and 5 s/step. The results
were obtained from XRD-6000 software programs.
3.3.3. Water sorption characteristics
Sorption proﬁles were determined using an automated water sorp-
tion analyzer (DVS-2, Surface measurement systems Ltd., London, UK).
The DVS-2 measures the uptake and loss of vapor gravimetrically
using a recording microbalance. The relative humidity around the sam-
ple was controlled by mixing saturated and dry carrier gas streams
using mass ﬂow controllers. The temperature was kept constant. Prior
to being exposed to any water vapor the sample was dried at O% RH
to remove any water present. Next, the sample was exposed to the de-
sired relative humidity and the moisture uptake was measured. This
was performed over a series of relative humidities at 25 °C. The amount
of water adsorbed and/or desorbed was expressed as a percentage of
the dry sample. More speciﬁcally, approximately 100 mg of sample
was weighed into the sample pan of the DVS and subjected to two
0–90% relative humidity (RH) sorption cycles, over 10% RH increments.
Equilibrium sorption at each humidity stepwas determined by a change
in mass to time ratio of 0.007 dm/dt. Each sample was submitted to
three sorption–desorption cycles.
3.3.4. Acid stability
The stability of the spray dried microspheres in 0.1 N HCl was
determined by incubating 0.5% w/v suspension of the microspheres
in 0.1 N HCl for 60 min and measuring the transmission of the sam-
ples at 500 nm (Spectrophotometer CINTRA 10E, GBC Melbourne,
Australia) after they had been exposed to the acidic medium, as al-
ready reported [44,45].
3.3.5. Biological assays
3.3.5.1. Nitric oxide production by macrophages. Macrophages were ob-
tained by the peritoneal lavage of BALB/c mice. Peritoneal cells were
allowed to adhere to 96-well culture microplates (TPP) at 4 × 105
cells/well in 100 μl of DMEM medium. After 1 h at 37 °C and 5% CO2,
the non-adherent cells were removed and the adherent macrophages
were cultured for a further 48 h in the presence or absence of increasing
concentrations of spray driedmicrospheres in 200 μl of DMEMmedium
plus 10% heat inactivated fetal calf serum and 1% DMSO. For positive
stimulation, cells were cultured with 1 μg ml−1 of lipopolysaccharide
(LPS). Untreated cells were cultured in medium alone. At the end of in-
cubation, the culture plates were centrifuged at 500 rpm during 5 min,
and the nitric oxide production was indirectly determined in the cell
culture supernatants by its nitrite oxidation product using the colori-
metric Griess method [58].
3.3.5.2. Cytotoxicity. The release of cytoplasmic lactate dehydrogenase
(LDH) is indicative of cell lysis. Macrophages were cultured and
treated with spray dried microspheres as above, and at the end of
incubation, the supernatants were collected. For maximum release,
cells were cultured in 2% Triton X-100, and for spontaneous release,
cells were cultured in medium alone. LDH activity was determined
by a colorimetric commercial kit (from Doles), according to the
manufacturer's instructions. The percentage of speciﬁc release was
calculated as (test release − spontaneous release) / (maximum
release − spontaneous release) × 100.
3.3.6. Preparation and characterization of composite microspheres as drug
delivery systems: preliminary studies
3.3.6.1. Preparation. Chitosan microspheres were found to have great
utility in drug carrier and delivery systems [24,47,48]. Preliminary stud-
ies were conducted in this work to evaluate the performance of the
chitosan–Aerosil R972 microspheres onto the drug release. Rifampicin
was chosen as a model lipophilic drug to test the release behavior of
the composite microspheres. Rifampicin is a class II drug of Biopharma-
ceutical Classiﬁcation System (BCS), where rate and extent of dissolu-
tion are critical for optimum bioavailability [49]. The objective was to
verify if the composite microspheres could delay the rifampicin release
rate in simulated gastric ﬂuid pH conditions. Experiments were per-
formed following the same experimental procedure described for the
production of the unloaded composite microspheres. Rifampicin
(0.1 g) was added to the hydroalcoholic chitosan–silica dispersion be-
fore the high-pressure homogenization step.
3.3.6.2. Characterization. In U.S. Pharmacopeia (USP), 0.1 N HCI is an of-
ﬁcial dissolution medium to evaluate the in-vitro dissolution kinetics of
rifampicin [50]. To carry out the in vitro release, a USP type II dissolution
apparatus (paddle method) was used. Approximately 500 mg of
rifampicin-loaded composite microspheres was dispersed in 900 ml of
0.1 M HCl (pH 1.2) maintained at 37 ± 1 °C under continuous stirring
at 100 rpm for 2 h. The amount of drug introduced into the dissolution
media assured the presence of sink conditions (maximum drug concen-
tration≪Ceq). At selected time intervals, 5 ml samples were withdrawn
through a hypodermic syringe ﬁtted with a 0.4 mm Millipore ﬁlter and
assayed spectrophotometrically (Cintra 10E Spectrophotometer) at a
wavelength of 334 nm, to evaluate the amounts of drug dissolved. Exper-
imentsweremade in triplicate. Themean ofﬁvemeasurementswas used
to calculate the drug release from the drug-loaded composite micro-
spheres for each batch.
Besides in-vitro drug release, X-ray powder diffraction, scanning
electron (SEM) and laser diffraction granulometry were also used to
characterize the rifampicin-loaded composite microspheres, using the
experimental procedures already described in this paper for the unloaded
composite microspheres.
3.3.7. Statistical analysis
All data were expressed asmean ± SEM, and for all analyses P b 0.05
was considered as signiﬁcantly different.
4. Results and discussion
4.1. Contact angle of ethanol–water solutions on Aerosil R972
Wetting of different concentrations of water–ethanol solutions on
Aerosil R972pressed tablet surfaces is shown in Fig. 2. The transition be-
tween the two clearly deﬁned states ‘non-wetting’ and ‘wetting’ could
be identiﬁed from these experiments as shown in Fig. 2. This behavior
is attributed to a decrease in surface tension with increasing ethanol
concentration. The contact angle for ethanol–water solutions for Aerosil
R972 was found to decrease with increasing ethanol concentration, and
enters the ‘wetting’ region (Θ b90°) for an ethanol amount in the
ethanol–water solutions higher than 17% w/w.
4.2. Physical characterization of composite microspheres
Chitosan and composite microspheres were characterized with re-
spect to particle size, moisture content and superﬁcial area. Table 1 sum-
marizes the results.
Table 1 shows that in spite of the increase of the dispersion viscosity
with the increase of Aerosil R972 concentration, only small variations in
median diameterwere observed for the different samples. Therewas no
direct relationship between Aerosil R972 concentration and particle
size, suggesting that the manufacturing method generated particles
within a narrow size distribution regardless of silica concentration.
The analysis of the particles distribution revealed that 90% of the particles
were less than approximately 15 μm. Table 1 also shows that the speciﬁc
surface area of composite microspheres increased with the Aerosil R972
content from 3.0 ± 0.2 m2 g−1 (F1 sample) to 21.7 ± 0.7 m2 g−1 (F4
sample), which could be expected considering the high speciﬁc surface
area of the silica (110 ± 20 m2 g−1). The residual water content ranged
from 4.1 to 6.6% wt, increasing with the chitosan mass proportion.
Scanning ElectronMicroscopy (SEM) and Transmission ElectronMi-
croscopy (TEM)were used to examine the surface structure of the sam-
ples. In comparison, the SEMand TEM images of composite samples (F2,
F3 and F4) suggested no variability of particle morphology with the
Aerosil R972 concentration (data not shown). Representative SEM and
TEM micrographs of F1 and F4 samples are shown in Figs. 3 and 4, re-
spectively. As shown by these images, all spray dried powders consist
of spherical structures.
Fig. 3D shows the visible nanosized silica particles on the F4 sample
surfaces. From the TEM images (Fig. 4), it can be seen that these micro-
spheres exhibited good transparency, indicating that silica nanoparti-
cles did not aggregate, leading to the absence of phase separation in
the polymericmatrix. Therefore, the chitosan–Aerosil R972microspheres
could be considered as nanocomposites consisting of homogeneously dis-
persed reinforcement (nanosized silica) within the chitosanmatrix. From
this reinforcement we could expect an inﬂuence on the mechanical and
barrier properties of the composite microspheres.
To complete these data, the zeta potential of the spray dried micro-
spheres and Aerosil R972 was measured as a function of pH and the re-
sults are shown in Fig. 5. It can be seen that the surface charges of the
chitosan microspheres (F1) were positive in the range of pH 4.5 to 7.4.
Due to its polymeric cationic characteristics, chitosan can interact with
negatively charged Aerosil R972 also shown in Fig. 5. However, in
spite of these probable electrostatic interactions, the surface charges of
the composite microspheres were always positive even for F4, which
are composite structures strongly charged in silica. This observation is
of great importance, for example, when administering drugs bymucosal
routes, since positive charge originating from chitosan microspheres is
necessary for the interaction with negatively charged mucus, and con-
sequently, mucoadhesion.
4.3. Thermal behavior
Thermogravimetric analysis (TG) and differential thermal analysis
(DSC) were carried out under oxygen atmosphere to determine the in-
organic content of the composite microspheres and to investigate their
thermal stability. Table 2 summarizes the thermal parameters.
The inorganic content remaining after complete thermal degrada-
tion of the organic material at 800 °C is shown in Table 2. It ranged
from 21% to 58% into the chitosan microspheres loaded with Aerosil
R972. Fig. 6 shows the TG curves of the spray dried microspheres with
different Aerosil R972 loadings, in comparison tomicrospheres contain-
ing neat chitosan. It can be seen that (neat) chitosan microspheres
underwent a single stage of degradation in the range 198–243 °C
(Tpeak at 226 °C). All experiments were conducted in oxidative
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Fig. 2. Contact angle of ethanol–water solutions on Aerosil R972.
atmosphere. However, according to the literature, the main difference in
thermal degradation of chitosan in non-oxidative (nitrogen purge) and
in oxidative atmospheres occurs above 400 °C [46], where strong exo-
thermic effects can be observed in the presence of oxygen indicating
that an efﬁcient oxidation followed by further decomposition of oxidized
chitosan takes place. The degradationmechanism is very complex includ-
ing the dehydration, deacetylation and chain scission [51], but its under-
standing is out of the aims of this study.
Themain ﬁndings from these analysis are the remarkable shift of the
temperature of decomposition to higher values which appeared for the
chitosan microspheres containing 21.5% (F2) and 39.9% w/w of Aerosil
R972 (F3), as shown in Fig. 6 and given in Table 2. This is an indication
that the addition of Aerosil R972 nanosized particles promotes chitosan
stabilization against oxidative degradation. In summary, when the re-
sults of neat chitosanmicrospheres are compared to the results of chito-
san–Aerosil R972 microspheres in terms of thermal behavior, there are
many important differences which might be due to the interaction be-
tween chitosan and Aerosil R972.
To get more insight on the thermal behavior of the spray dried
composite microspheres, DSC measurements were performed and
the results are shown in Fig. 7. The DSC thermograms show broad
endothermic peaks over a large temperature range (b100 °C),
which is attributed to water loss due to evaporation of absorbed
water. The main event of these calorimetric curves is an exothermic
peak centered around 250–310 °C in Fig. 7 for chitosan (F1) and
composite (F2, F3 and F4) microspheres, owing to the thermal deg-
radation of the microspheres. The peak of pure chitosan is read at
251 °C. With the addition of Aerosil R972, this exothermic peak
shifted to the high temperature region (288–309 °C). This behavior
conﬁrms the results already shown by TGA analysis that Aerosil
R972 in appropriate content increased the thermal stability of the
chitosan microspheres.
4.4. Structural characterization
4.4.1. X-ray diffraction
The XRD technique is based on the elastic scattering of X-rays
from structures that have long-range order. It is an efﬁcient analyt-
ical technique to identify and characterize crystalline materials. The
X-ray diffraction patterns (Fig. 8) show that Aerosil R972 nanoparticles,
spray dried neat chitosan microspheres and composite microspheres
Table 1
Physical properties of chitosan–Aerosil R972 microspheres.
Code Chitosan: Aerosil R972
(theoretical mass proportion)
Suspension viscosity
at 25 °C (cp)
Water content
% (w/w)
Speciﬁc surface
area (m2 g−1)
D(4.3) (μm) D(0.1) (μm) D(0.9) (μm) Span
F1 1:0 20.4 ± 0.1 6.2 ± 0.9 3.0 ± 0.2 5.1 ± 0.1 1.9 ± 0.1 17.5 ± 2.1 2.4
F2 10:1 28.2 ± 0.2 6.6 ± 0.1 4.1 ± 0.3 6.6 ± 0.5 0.9 ± 0.1 15.3 ± 0.5 2.4
F3 2:1 37.1 ± 0.3 5.3 ± 0.1 8.8 ± 0.3 7.9 ± 0.1 2.6 ± 0.1 14.1 ± 0.6 1.7
F4 1:1 60.5 ± 0.5 4.1 ± 0.1 21.7 ± 0.7 5.9 ± 0.1 2.1 ± 0.1 10.5 ± 0.5 1.6
Fig. 3. SEM images of the composite microspheres. (A) and (B) F1 (neat chitosan); (C) and (D) F4 (58.1% Aerosil R972 loading).
can be identiﬁed as amorphous, due to the broad diffraction halo
they exhibited.
4.4.2. FT-IR spectroscopy
The bonding structure of the composite microspheres was further
investigated by FTIR spectroscopy. The FTIR spectra of F2, F3 and F4
samples (Fig. 9) present the characteristic peaks of chitosan and Aerosil
R972.
The spectra of unmodiﬁed chitosan microspheres (Fig. 9a)
showed a broad absorption band at 3444 cm−1 attributed to the
stretching vibrations of OH groups, which are overlapped to the
stretching vibration of N\H. The characteristic absorption of chito-
san is the band at 1595 cm−1, which is assigned to the stretching vi-
bration of amino group of chitosan and 1325 cm−1 assigned to vibration
of C\H. The peak at 1085 cm−1 indicates C\O stretching vibration
[52,53]. The peaks around 895 and 1155 cm−1 correspond to stretching
vibrations of C\O\C groups in saccharide structure of chitosan [54,55].
The FTIR spectra of Aerosil R972 (Fig. 9e) showed an absorption peak
at about 1109 cm−1, attributed to the asymmetric stretching vibrations
of the Si\O\Si bonds of silica oxide,while the peak at 810 cm−1 can be
attributed to the symmetric deformation of the Si\O\Si bonds. These
are typical absorption bands for Si\O\Si network vibrations [56].
The IR spectra of composite microspheres show the characteristic
bands of both chitosan and Aerosil R972 (Fig. 9b to d). They are of sim-
ilar shape; however, several characteristic bands are shifted, deformed
or disappeared, especially in the region between 1000 and 1400 cm−1.
Also for chitosan, the absorption band of amide II (1595 cm−1) is
shifted a little for the short wave (1560 cm−1) and the characteristic
bands in chitosan skeleton at 1032, 1155, 1032 and 895 cm−1 are
observed with slight intensity or disappeared (see Fig. 9d). This evi-
dences that the groups of these bands have taken part in bonding
with Aerosil R972.
4.5. Moisture sorption characteristics
The objective here was to verify the effects of Aerosil R972 on the
barrier properties of chitosan against high humidity. The equilibri-
um moisture sorption isotherms (ﬁrst sorption cycle) for each of
the samples are plotted in Fig. 10. Although two cycles were con-
ducted for each material, moisture desorption from the ﬁrst cycle
was reversible. Subsequently, such data were omitted for better
clarity between samples.
The results suggest that the afﬁnity of composite microspheres for
moisture sorption decreased, compared to neat chitosan microspheres.
To further investigate the relationship between moisture sorption and
the relative concentration of silica in the composite microspheres, the
equilibrium mass content of each sample at high relative humidity
(70% RH used as a percentage of reference) was plotted against Aerosil
R972 concentration (Fig. 11). The analysis in Fig. 11 also suggested a di-
rect linear relationship between moisture sorption at 70% RH and
Aerosil R972 concentration (R2 = 0.9986), with increased silica content
resulting in a decreased afﬁnity for moisture sorption.
4.6. Acid stability
Chitosan is soluble in acidic pH, therefore, the purpose of carrying
out this study that we called ‘acid stability experiment’ was to measure
the effect of silica on the solubility of composite microspheres in acidic
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Fig. 4. TEM images of the composite microspheres. (A) and (B) F4 (58.1% Aerosil R972 loading).
Fig. 5. Zeta potential of composite microspheres and neat Aerosil R972 as a function of pH.
medium. The light transmission data in Table 3 are presented as per-
centages. The 0.1 N HCl is the sample providing 100% transmission.
Chitosan microspheres dissolved in the acidic medium leading to a
mediummore transparent (92% transmission). However, if the particles
do not dissolve, the light transmission through the medium decreases.
Since the decrease in turbidity is directly dependent on the dissolution
of the microspheres, transmission is a measure of the concentration of
non-dissolved microspheres. To sum up, a low transmission indicates
high stability of microspheres in the acidic medium (low or slow disso-
lution rate), and a high transmission implies that the microspheres dis-
solved in HCl.
It can be observed in Table 3 that increasing Aerosil R972 loadings
reduced % light transmission through the suspensions, suggesting that
microspheres dissolved more slowly. Presumably, this “acid-stability”
arises by virtue of coating the surface of the microsphere with non-
acid-labile silica, thereby preventing contact between the acid and the
chitosan, which would otherwise dissolve.
4.7. Biological assays
The composite microspheres with the highest Aerosil R972 loading
(F4) were chosen for biological assays due to their properties (better
chemical resistance in acidic medium, reduced moisture afﬁnity).
Their capacity to activatemacrophages to produce nitric oxidewas test-
ed as an indication of pro-inﬂammatory potential. Microspheres con-
taining only chitosan (F1 sample) were also tested as control.
Fig. 12 shows that concentrations of either particles as high as
1000 μg ml−1 did not stimulate macrophages to produce nitric oxide,
compatible with a low pro-inﬂammatory action. The capacity of F1
and F4 microspheres to induce cytotoxicity was evaluated by their ca-
pacity to induce cytoplasmic LDH leakage from macrophages. Fig. 13
shows that despite their similar concentrations necessary to produce
50% of cell lysis (IC50, 220 μg ml−1 and 237 μg ml−1, respectively), at
concentrations lower than 100 μg ml−1, F4 is less (P b 0.05) cytotoxic
than F1. Together, these results indicate that F1 and F4 microspheres
are not prone to induce inﬂammation, and that coatingwith 58% Aerosil
Table 2
Thermal parameters obtained from thermogravimetric analysis of chitosan in oxygen
temperature.
Code Chitosan: Aerosil
R972 (theoretical
mass proportion)
Inorganic loading
% (w/w)a
Chitosan decomposition
temperature
Tonset (°C) Tpeak (°C)
F1 1:0 0 198 226
F2 10:1 21.5 ± 0.3 217 248
F3 2:1 39.9 ± 0.4 251 282
F4 1:1 58.1 ± 0.7 252 285
a Ash remaining after complete degradation of samples at 800 °C.
Fig. 6. TGA thermograms (A) and derivativemass loss (DTG) (B) versus temperature, with
heating rate of 10 °C min−1 for composite microspheres with different Aerosil R972
loadings: (a) F1 (neat chitosan), (b) F2 (21.5%), (c) F3 (39.9%), (d) F4 (58.1%), and
(e) neat Aerosil R972.
Fig. 7.DSC thermograms for compositemicrosphereswith differentAerosil R972 loadings:
(a) F1 (neat chitosan), (b) F2 (21.5%), (c) F3 (39.9%), (d) F4 (58.1%), and (e) neat Aerosil
R972.
R972 as in F4 rendered chitosanmicrospheresmore biocompatible. This
effect is possibly due to a stealth effect of hydrophobic silica preventing
strong electrostatic interaction of cationic chitosan with the negatively
charged cell membrane and cytosol leakage.
4.8. Composite microspheres as drug delivery systems: preliminary studies
Consistently with our attempt, a synergistic effect of chitosan and
Aerosil R972 as well as some possible interfacial interactions between
themvia electrostatic interactions andH-bonds could change properties
of the spray dried compositemicrospheres such as thermal degradation,
moisture afﬁnity and acid stability. Preliminary studies were conducted
to evaluate the performance of the composite microspheres onto the
drug release at acidic conditions, using rifampicin as model drug.
The formulation of choicewas F4 (58.1%Aerosil R972) due to its best
performance to control chitosan dissolution in acidic medium demon-
strated from the acid stability experiments. F1 was used as control
(neat chitosan). The new formulations were named rifampicin-loaded
F1 and rifampicin-loaded F4, respectively.
Fig. 14 presents the SEM images of raw rifampicin and the
rifampicin-loaded F4microspheres. The raw rifampicin had an irregular
shape and broad particle size distribution ranging from 39 to 603 μm
(particle size distribution determined by laser diffraction analysis, data
not shown). Evidently, the particle size of the spray dried rifampicin is
Fig. 8. DRX diffractograms for composite microspheres with different Aerosil R972
loadings: (a) F1 (neat chitosan), (b) F2 (21.5%), (c) F3 (39.9%), (d) F4 (58.1%), and
(e) neat Aerosil R972.
Fig. 9. FTIR spectra for composite microspheres with different Aerosil R972 loadings:
(a) F1 (neat chitosan), (b) F2 (21.5%), (c) F3 (39.9%), (d) F4 (58.1%), and (e) neat Aerosil
R972.
Fig. 10. DVS sorption isotherms for spray dried composite microspheres with varying
percentages of Aerosil R972.
Fig. 11. Mean moisture sorption at 70% RH plotted as a function of Aerosil R972
concentration.
Table 3
Acid stability of chitosan–Aerosil R972 microspheres.
Code Chitosan: Aerosil R972
(theoretical mass proportion)
Inorganic loading
% (w/w)
% light
transmission
F1 1:0 0 92.1 ± 0.3
F2 10:1 21.5 ± 0.3 72.9 ± 0.4
F3 2:1 39.9 ± 0.4 30.0 ± 0.8
F4 1:1 58.1 ± 0.7 10.6 ± 2.8
signiﬁcantly smaller and more uniform than that of the raw drug.
Rifampicin-loaded F4 sample exhibited regular spherical structure and
particle size close to those of the unloaded composite microspheres
(ranging from 2 to 12 μm, data measured by laser diffraction analysis,
not shown).
X-raydiffraction analysis conﬁrmed that formulation process altered
the crystalline nature of rifampicin. The corresponding X-ray diffraction
patternswere displayed in Fig. 15. It can be seen that the raw rifampicin
exhibited intense crystalline peaks between 10° and 30°. However, a
broad and diffuse maxima peak at 22° was detected in the pattern of
rifampicin-loaded F4microspheres, demonstrating the reduced crystal-
line nature of the powder.
The in vitro release proﬁles are compared in Fig. 16. Firstly, this ﬁg-
ure shows that raw rifampicin dissolved more slowly than spray-dried
rifampicin, due to a higher surface area (smaller particles) and lower de-
gree of crystallinity. It is known that transforming the physical state of
the drug (crystalline to amorphous) would lead to a high-energy state
and high disorder, resulting in enhanced dissolution rate [57]. Secondly,
rifampicin-loaded F1 microspheres (neat chitosan) did not delay the
dissolution of the drug in the acidic medium, the dissolution was even
to close to that of the control (immediate release). In turn, the results
of thedissolution kinetics of rifampicin-loaded F4microspheres showed
signiﬁcantly (P b 0.05) reduced percentage drug release compared to
rifampicin-loaded F1 microspheres.
The present study aimed at testing a protector effect of the compos-
ite microsphere membrane against rifampicin dissolution in acidic me-
dium. The drug release could be extended under acidic conditionwithin
the ﬁrst 30 min when rifampicin was loaded in rifampicin-loaded F4
microspheres.
5. Conclusions
In this study we proposed to develop spray-dried microspheres
composed of chitosan and hydrophobic silica particles aiming at in-
creased thermal and acidic stabilities, as well as improved drug release
properties in acidic medium.
Loading the chitosan microspheres with up to 58% Aerosil R972 did
not alter signiﬁcantly their average particle size, however the speciﬁc
surface area was increased. Increasing the Aerosil R972 content led to
increased thermal and acid stability, and also lower moisture afﬁnity.
Fig. 12. Lack of stimulation of nitric oxide production by macrophages. Mouse peritoneal
macrophages (5 × 105) were cultured at 37 °C for 48 h in 200 μl of medium containing
varying concentrations of F1 and F4, as indicated. The supernatants were collected, and
the nitrite concentration was colorimetrically determined using the Griess method. Positive
controls were cells cultured with 1 μg ml−1 of lipopolysaccharide (LPS, OD = 2.05).
Negative controls were cells in medium with 1% DMSO (OD = 0.43). Means ± SD, n = 3.
Representative of 2 different experiments using different batches of samples.
Fig. 13. Cytotoxicity to macrophages: mouse peritoneal macrophages were incubated for
48 h in the presence of varying concentrations of F1 and F4 as indicated. At the end of
incubation time the cell supernatants were collected for colorimetric measurement of
the released lactate dehydrogenase. For maximum (100%) release, cells were cultured
with 2% Triton X-100 (OD = 1.36). For spontaneous release, cells were cultured in medium
with 1%DMSO (OD = 0.14).Means ± SD, n = 3. *P b 0.05 in relation to F4. Representative
of two different experiments using different batches of samples.
Fig. 14. SEM images of: (A) raw rifampicin, (B) rifampicin-loaded composite microspheres (rifampicin-loaded F4).
Rifampicin-loaded F4
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Fig. 15. DRX diffractograms for: raw rifampicin and rifampicin-loaded composite
microspheres (rifampicin-loaded F4).
The improved properties were attributed to some interaction likely
through hydrogen bonds between hydrophobic (Aerosil R972) and
hydrophilic components (chitosan), which were conﬁrmed by the struc-
tural characterization studies.
In vitro studies indicated low cytotoxicity and low capacity to
activate cell production of the pro-inﬂammatory mediator nitric oxide.
Together these ﬁndings encourage further exploration of our chitosan–
hydrophobic silica microspheres as novel oral or mucosal drug delivery
systems.
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